Combined low-intensity extracorporeal shock wave therapy and platelet-rich plasma in acute-phase Peyronie’s disease
Pamukkale Medical Journal · 10.07.2026 · 19 (3) · 632-640
DOI: 10.31362/patd.1943701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pamukkale Medical Journal, online erschienen am 10.07.2026. Verfasst von Yusuf Özlülerden und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Gefördert von: The authors received no financial support for the research, authorship, and/or publication of this article..
Abstract (Originalsprache)
Purpose
To evaluate the efficacy, safety, and tolerability of combined low-intensity extracorporeal shock wave therapy and platelet-rich plasma in patients with acute-phase Peyronie’s disease.Materials and methods: This retrospective single-center study included 42 men with acute-phase Peyronie’s disease treated between January 2025 and January 2026. The acute phase was defined as a symptom duration of less than 6 months. All patients received daily tadalafil, six sessions of low-intensity extracorporeal shock wave therapy, and three intralesional platelet-rich plasma injections. Penile curvature, plaque size, penile pain, and erectile function were assessed before treatment and 3 months after treatment. Penile pain was evaluated with a visual analog scale, and erectile function was assessed using the International Index of Erectile Function. Paired comparisons were performed according to data distribution.
Results
The median pain score decreased significantly from 7.00 to 3.50 (p<0.001). Erectile function also improved significantly, with the mean score increasing from 16.59±4.51 to 20.88±5.51 (p<0.001). Mean penile curvature decreased from 33.89±10.49 degrees to 31.53±13.26 degrees, but this change was not significant (p=0.058). Mean plaque size changed from 1.58±0.45 cm to 1.56±0.46 cm without statistical significance (p=0.594). No major adverse events were observed. Minor local complications included mild ecchymosis in 11.9% and transient edema in 4.8% of patients.
Conclusion
Combined low-intensity extracorporeal shock wave therapy and platelet-rich plasma appears to be a safe and effective conservative treatment option in acute-phase Peyronie’s disease. The protocol provided significant pain relief and improved erectile function, while stabilizing penile curvature and plaque size
Förderung
- The authors received no financial support for the research, authorship, and/or publication of this article.
Zitieren
APA
Özlülerden, Y., Akinci, A., Küçüker, K., Gökçedağ, İ., Duran, M. B., & Çelen, S. (2026). Combined low-intensity extracorporeal shock wave therapy and platelet-rich plasma in acute-phase Peyronie’s disease. Pamukkale Medical Journal, 19(3), 632-640. https://doi.org/10.31362/patd.1943701
Vancouver
Özlülerden Y, Akinci A, Küçüker K, Gökçedağ İ, Duran MB, Çelen S. Combined low-intensity extracorporeal shock wave therapy and platelet-rich plasma in acute-phase Peyronie’s disease. Pamukkale Medical Journal. 2026;19(3):632-640. doi:10.31362/patd.1943701
BibTeX
@article{zllerden2026,
author = {Özlülerden, Yusuf and Akinci, Aykut and Küçüker, Kürşat and Gökçedağ, İlker and Duran, Mesut Berkan and Çelen, Sinan},
title = {Combined low-intensity extracorporeal shock wave therapy and platelet-rich plasma in acute-phase Peyronie’s disease},
journal = {Pamukkale Medical Journal},
year = {2026},
volume = {19},
number = {3},
pages = {632--640},
doi = {10.31362/patd.1943701}
}
EUVIMED